L-type calcium channel disease

Electrical Diseases of the Heart

Volumn 1, Issue , 2013, Pages 209-217

  Ruan, Yanfei ^a   Bloise, Raffaella ^b   Napolitano, Carlo ^c   Priori, Silvia G ^a,b,d  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b IRCCS   (Italy)

^c NEW YORK UNIVERSITY   (United States)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

Calcium handling; Cardiac channelopathies; Genetics; Inherited arrhythmias; Ion channels; Sudden cardiac death; Ventricular fibrillation

Indexed keywords

EID: 84927925251     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4471-4881-4_12     Document Type: Chapter

References (30)

1. Striessnig J, Bolz HJ, Koschak A. Channelopathies in Cav1.1, Cav1.3, and Cav1.4 voltage-gated L-type Ca2+ channels. Pflugers Arch. 2010;460:361-74.
2. Antzelevitch C, Pollevick GD, Cordeiro JM, et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation. 2007;115: 442-9.
3. Burashnikov E, Pfeiffer R, Barajas-Martinez H, et al. Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. Heart Rhythm. 2010;7:1872-82.
4. Napolitano C, Antzelevitch C. Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac voltage-dependent L-type calcium channel. Circ Res. 2011;108:607-18.
5. Splawski I, Timothy KW, Sharpe LM, et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell. 2004;119:19-31.
6. Catterall WA. Structure and regulation of voltagegated Ca2+ channels. Annu Rev Cell Dev Biol. 2000;16:521-55.
7. Bezanilla F. Voltage sensor movements. J Gen Physiol. 2002;120:465-73.
8. Klockner U, Mikala G, Schwartz A, et al. Molecular studies of the asymmetric pore structure of the human cardiac voltage-dependent Ca2+ channel. Conserved residue, Glu-1086, regulates protondependent ion permeation. J Biol Chem. 1996;271: 22293-6.
9. Hanlon MR, Wallace BA. Structure and function of voltage-dependent ion channel regulatory beta subunits. Biochemistry. 2002;41:2886-94.
10. Klugbauer N, Marais E, Hofmann F. Calcium channel alpha2delta subunits: differential expression, function, and drug binding. J Bioenerg Biomembr. 2003;35:639-47.
11. De Jongh KS, Murphy BJ, Colvin AA, et al. Specific phosphorylation of a site in the full-length form of the alpha 1 subunit of the cardiac L-type calcium channel by adenosine 3',5'-cyclic monophosphate-dependent protein kinase. Biochemistry. 1996;35:10392-402.
12. Lacerda AE, Rampe D, Brown AM. Effects of protein kinase C activators on cardiac Ca2+ channels. Nature. 1988;335:249-51.
13. Qin N, Olcese R, Bransby M, et al. Ca2+-induced inhibition of the cardiac Ca2+ channel depends on calmodulin. Proc Natl Acad Sci U S A. 1999;96:2435-8.
14. Zuhlke RD, Pitt GS, Deisseroth K, et al. Calmodulin supports both inactivation and facilitation of L-type calcium channels. Nature. 1999;399:159-62.
15. van der Heyden MA, Wijnhoven TJ, Opthof T. Molecular aspects of adrenergic modulation of cardiac L-type Ca2+ channels. Cardiovasc Res. 2005;65:28-39.
16. Gurney AM, Charnet P, Pye JM, et al. Augmentation of cardiac calcium current byflash photolysis of intracellular caged-Ca2+ molecules. Nature. 1989;341:65-8.
17. Dzhura I, Wu Y, Colbran RJ, et al. Calmodulin kinase determines calcium-dependent facilitation of L-type calcium channels. Nat Cell Biol. 2000;2:173-7.
18. Liao P, Yong TF, Liang MC, et al. Splicing for alternative structures of Cav1.2 Ca2+ channels in cardiac and smooth muscles. Cardiovasc Res. 2005;68:197-203.
19. Reichenbach H, Meister EM, Theile H. The hearthand syndrome. A new variant of disorders of heart conduction and syndactylia including osseous changes in hands and feet. Kinderarztl Prax. 1992;60:54-6.
20. Marks ML, Whisler SL, Clericuzio C, et al. A new form of long QT syndrome associated with syndactyly. J Am Coll Cardiol. 1995;25:59-64.
21. Splawski I, Timothy KW, Decher N, et al. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci U S A. 2005;102:8089-96; discussion 8086-8.
22. Splawski I, Yoo DS, Stotz SC, et al. CACNA1H mutations in autism spectrum disorders. J Biol Chem. 2006;281:22085-91.
23. Tang ZZ, Sharma S, Zheng S, et al. Regulation of the mutually exclusive exons 8a and 8 in the CaV1.2 calcium channel transcript by polypyrimidine tract-binding protein. J Biol Chem. 2011;286:10007-16.
24. Etheridge SP, Bowles NE, Arrington CB, et al. Somatic mosaicism contributes to phenotypic variation in Timothy syndrome. Am J Med Genet A. 2011;155:2578-83.
25. Erxleben C, Liao Y, Gentile S, et al. Cyclosporin and Timothy syndrome increase mode 2 gating of CaV1.2 calcium channels through aberrant phosphorylation of S6 helices. Proc Natl Acad Sci U S A. 2006;103:3932-7.
26. Thiel WH, Chen B, Hund TJ, et al. Proarrhythmic defects in Timothy syndrome require calmodulin kinase II. Circulation. 2008;118:2225-34.
27. Cheng EP, Yuan C, Navedo MF, et al. Restoration of normal L-type Ca2+ channel function during Timothy syndrome by ablation of an anchoring protein. Circ Res. 2011;109:255-61.
28. Bader PL, Faizi M, Kim LH, et al. Mouse model of Timothy syndrome recapitulates triad of autistic traits. Proc Natl Acad Sci U S A. 2011;108: 15432-7.
29. Yazawa M, Hsueh B, Jia X, et al. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature. 2011; 471:230-4.
30. Shah DP, Baez-Escudero JL, Weisberg IL, et al. Ranolazine safely decreases ventricular and atrialfibrillation in Timothy syndrome (LQT8). Pacing Clin Electrophysiol. 2012;35(3):e62-4.